|
Name |
(+)-aS-alterporriol C
|
| Molecular Formula | C32H26O13 | |
| IUPAC Name* |
1-(1,5,6,7,8-pentahydroxy-3-methoxy-7-methyl-9,10-dioxo-6,8-dihydro-5H-anthracen-2-yl)-2,8-dihydroxy-6-methoxy-3-methylanthracene-9,10-dione
|
|
| SMILES |
COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(-c3c(OC)cc4c(c3O)C(=O)C3=C(C4=O)C(O)C(C)(O)C(O)C3O)c1C2=O
|
|
| InChI |
InChI=1S/C32H26O13/c1-9-5-11-17(26(37)16-12(24(11)35)6-10(44-3)7-14(16)33)20(23(9)34)19-15(45-4)8-13-18(27(19)38)28(39)21-22(25(13)36)30(41)32(2,43)31(42)29(21)40/h5-8,29-31,33-34,38,40-43H,1-4H3/t29-,30+,31+,32-/m0/s1
|
|
| InChIKey |
PSGFKGASHCTNSI-BVEPWEIPSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 618.55 | ALogp: | 1.1 |
| HBD: | 7 | HBA: | 13 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 228.3 | Aromatic Rings: | 6 |
| Heavy Atoms: | 45 | QED Weighted: | 0.173 |
| Caco-2 Permeability: | -6.439 | MDCK Permeability: | 0.00000531 |
| Pgp-inhibitor: | 0.704 | Pgp-substrate: | 0.006 |
| Human Intestinal Absorption (HIA): | 0.941 | 20% Bioavailability (F20%): | 0.025 |
| 30% Bioavailability (F30%): | 0.999 |
| Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 92.97% |
| Volume Distribution (VD): | 0.295 | Fu: | 8.29% |
| CYP1A2-inhibitor: | 0.614 | CYP1A2-substrate: | 0.903 |
| CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.054 |
| CYP2C9-inhibitor: | 0.366 | CYP2C9-substrate: | 0.083 |
| CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.156 |
| CYP3A4-inhibitor: | 0.054 | CYP3A4-substrate: | 0.054 |
| Clearance (CL): | 2.254 | Half-life (T1/2): | 0.094 |
| hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.083 |
| Drug-inuced Liver Injury (DILI): | 0.981 | AMES Toxicity: | 0.497 |
| Rat Oral Acute Toxicity: | 0.052 | Maximum Recommended Daily Dose: | 0.934 |
| Skin Sensitization: | 0.862 | Carcinogencity: | 0.006 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.54 |
| Respiratory Toxicity: | 0.089 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002596 | ![]() |
0.778 | D01XWG | ![]() |
0.282 | ||
| ENC005390 | ![]() |
0.778 | D0C9XJ | ![]() |
0.277 | ||
| ENC000947 | ![]() |
0.678 | D07VLY | ![]() |
0.277 | ||
| ENC000911 | ![]() |
0.678 | D0T5XN | ![]() |
0.267 | ||
| ENC003207 | ![]() |
0.571 | D0AZ8C | ![]() |
0.246 | ||
| ENC003729 | ![]() |
0.535 | D01UBX | ![]() |
0.246 | ||
| ENC003770 | ![]() |
0.535 | D09LBS | ![]() |
0.245 | ||
| ENC000995 | ![]() |
0.528 | D0Z2LG | ![]() |
0.245 | ||
| ENC000783 | ![]() |
0.525 | D07IPB | ![]() |
0.240 | ||
| ENC005226 | ![]() |
0.484 | D0FX2Q | ![]() |
0.240 | ||